PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies | Zendy

Stephen N. Gomperts | Zendy; Marta Marquié | Zendy; Joseph J. Locascio | Zendy; Steve Bayer | Zendy; Keith A. Johnson | Zendy; John H. Growdon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies

Author(s) -

Stephen N. Gomperts,

Marta Marquié,

Joseph J. Locascio,

Steve Bayer,

Keith A. Johnson,

John H. Growdon

Publication year - 2015

Publication title -

neurodegenerative diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.98

H-Index - 57

eISSN - 1660-2862

pISSN - 1660-2854

DOI - 10.1159/000441421

Subject(s) - dementia with lewy bodies , pittsburgh compound b , dementia , parkinson's disease , medicine , cognitive decline , dopamine transporter , neuropsychology , putamen , psychology , lewy body , neuropathology , cognitive impairment , disease , pathology , neuroscience , cognition , dopamine , dopaminergic

Effective therapies for dementia with Lewy bodies (DLB) and Parkinson's disease (PD) dementia will require accurate diagnosis and an understanding of the contribution of distinct molecular pathologies to these diseases. We seek to use imaging biomarkers to improve diagnostic accuracy and to clarify the contribution of molecular species to cognitive impairment in DLB and PD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research